Profound Medical Corp. (PROF)
NASDAQ: PROF
· Real-Time Price · USD
4.33
-1.21 (-21.84%)
At close: Aug 15, 2025, 3:59 PM
4.60
6.24%
After-hours: Aug 15, 2025, 04:55 PM EDT
Profound Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -32.42M | -28.28M | -31.85M | -27.98M | -28.41M | -28.57M | -29.19M | -28.62M | -27.2M | -28.67M | -29.3M | -30.3M | -31.41M | -30.7M | -27.9M | -28.14M | -26.58M |
Depreciation & Amortization | 794K | 936K | 1.16M | 1.18M | 1.17M | 1.15M | 1.1M | 1.19M | 1.41M | 1.6M | 1.84M | 1.96M | 1.93M | 1.88M | 1.77M | 1.68M | 1.6M |
Stock-Based Compensation | 2.8M | 2.58M | 3.05M | 3.17M | 3.24M | 3.42M | 3.08M | 3.56M | 4.3M | 4.24M | 6.09M | 6.87M | 6.98M | 7.21M | 5.72M | 4.72M | 3.68M |
Other Working Capital | -487.54K | -1.97M | 284.46K | -6K | -553K | 700.91K | 223.81K | -1.49M | -1.22M | -1.78M | -1.7M | -1.25M | -799K | 65K | 92.48K | 1.35M | 1.08M |
Other Non-Cash Items | 293K | 255K | 792K | 845K | 739K | 982K | 3.5M | 3.24M | 2.88M | 2.66M | -10K | 14K | 232K | 425K | 339.97K | 498.63K | 487.89K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 353K | 353K | 353K | 353K | n/a | n/a | -110K | -144K | -272K | -293K | 131.04K | 1.16M | 2.56M |
Change in Working Capital | 1.47M | 249K | 1.22M | -404K | 952K | 374K | -740K | -3.03M | -5.16M | -5.63M | -2.74M | -1.9M | -1.41M | -877K | -4.47M | -3.83M | -3.47M |
Operating Cash Flow | -26.64M | -22.88M | -24.26M | -22.23M | -21M | -22.3M | -21.9M | -23.32M | -23.76M | -25.8M | -24.23M | -23.5M | -23.95M | -22.36M | -24.41M | -23.91M | -21.72M |
Capital Expenditures | 0.73 | -0.87 | -0.03 | -1.03 | -0.76 | 0.84 | n/a | n/a | n/a | n/a | -127K | -248K | -412K | -593K | -466K | -345K | -181K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -350K | -350K | -350K |
Investing Cash Flow | n/a | n/a | n/a | n/a | 239K | 239K | 239K | 239K | n/a | n/a | -127K | -248K | -412K | -593K | -816K | -408.59K | 275.41K |
Debt Repayment | -2.08M | -2.49M | -2.46M | -2.02M | -1.59M | -1.17M | 6.48M | 6.56M | 6.72M | 6.92M | -340K | -350K | -362K | -386K | -358.94K | -335.94K | -310.94K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.28M | -4.85M | -1.85M | -1.89M | -1.98M | 3.05M | 2.9M | 3.1M | 3.29M | 114K | 275K | 5.83M | 6.27M | 7.89M | 15.97M | 23.87M | 25.11M |
Financial Cash Flow | 34.17M | 54.91M | 18.77M | 19.17M | 19.54M | 1.23M | 8.72M | 9M | 9.25M | 7.03M | -65K | 4.33M | 4.67M | 5.95M | 12.14M | 54.38M | 55.73M |
Net Cash Flow | 5.25M | 28.7M | -6.5M | -5.2M | -1.8M | -20.3M | -12.58M | -13.96M | -17.14M | -20.64M | -26.01M | -20.54M | -18.39M | -16.76M | -10.26M | 32.8M | 34.87M |
Free Cash Flow | -26.97M | -23.22M | -24.59M | -22.1M | -21M | -22.3M | -21.9M | -23.32M | -23.76M | -25.8M | -24.36M | -23.75M | -24.36M | -22.95M | -24.88M | -24.25M | -21.9M |